Hutch News
Eight promising projects win Evergreen Fund grants to promote commercialization of research
A dozen scientists to receive up to $200K from 3-year-old Fred Hutch program
New HIV vaccine trial to launch in U.S., Latin America and Europe
‘Mosaico’ will enroll 3,800 transgender people and men who have sex with men
Engineering B cells to bypass vaccines
From the Taylor Lab, Vaccine and Infectious Disease Division
Dr. M. Elizabeth ‘Betz’ Halloran receives Nathan Mantel Lifetime Achievement Award
Biostatistician honored for her landmark contributions to statistical methods for infectious disease epidemiology
Raquel Sanchez named managing director of Global Oncology
Research administrator brings 20 years of experience to Seattle- and Kampala-based teams
Infections in immune-compromised patients: 5 new frontiers
Infectious disease experts gather in Seattle to find solutions for patients with compromised immunity
.JPG)
London transplant doctors report a second person likely cured of HIV
12 years after Timothy Ray Brown was cured, we have another
Scientists strategize to stop HIV infections, work toward cure
A hot topic for a big scientific conference convening in Seattle
.jpg)
Rethinking an old viral foe
Why does a common virus plague bone marrow transplant patients? New study challenges dogma, opens door to new therapies.
Cancer Research in 2019: Why we are counting on data science and tech to defeat cancer
Why we are counting on data science and tech to defeat cancer
Why now is the time to get your flu shot
Protecting yourself also helps those around you, especially cancer patients vulnerable to influenza
Guiding inactivity of latent HIV reservoirs
From the Jerome lab, Vaccine and Infectious Disease Division
Models aren’t just pretty
From the Schiffer lab, Vaccine and Infectious Disease Division
Washington’s Andy Hill Cancer Research Endowment awards $1.5M to 3 Fred Hutch researchers
Scientists will use funds to expand research in graft-vs.-host disease, chemoprevention and cancer immunology
Breaking tolerance: a story of two mechanisms and one disease
Gottardo Laboratory, Vaccine and Infectious Disease Division
Computational biologist Dr. Raphael Gottardo receives 2018 Mortimer Spiegelman Award
American Public Health Association recognizes Fred Hutch researcher for his contributions to health statistics biology
UCI-Fred Hutch collaboration turns 10
In Uganda, innovation and persistence allow a 'sustainable cancer program' to take root
The pride of Fred Hutch
HIV Vaccine Trials Network veteran Steven Wakefield named a grand marshal in Seattle Pride Parade
Dr. Joshua Hill receives Amy Strelzer Manasevit grant award
Award will help fund ‘paradigm shift’ in diagnosing post-transplant infections
Double trouble: epithelial and B cell neutralization of Epstein-Barr virus
McGuire Laboratory, Vaccine and Infectious Disease Division
MAIT cells get around
From the Prlic Laboratory, Vaccine and Infectious Disease Division
Physician assistant Debra Mattson to retire May 24
She has been the historian — and the heart —of the Infectious Disease Consult Service
First human antibody found to block Epstein-Barr virus
Early research could open new path for vaccine against EBV-related cancers, mononucleosis
With approval of new CMV drug for transplant patients, a legacy continues
Tissue samples from a clinical trial conducted decades ago yield new insights and treatments